1. Home
  2. RXRX vs EVT Comparison

RXRX vs EVT Comparison

Compare RXRX & EVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RXRX
  • EVT
  • Stock Information
  • Founded
  • RXRX 2013
  • EVT 2003
  • Country
  • RXRX United States
  • EVT United States
  • Employees
  • RXRX N/A
  • EVT N/A
  • Industry
  • RXRX Biotechnology: Pharmaceutical Preparations
  • EVT Finance Companies
  • Sector
  • RXRX Health Care
  • EVT Finance
  • Exchange
  • RXRX Nasdaq
  • EVT Nasdaq
  • Market Cap
  • RXRX 2.0B
  • EVT 1.7B
  • IPO Year
  • RXRX 2021
  • EVT N/A
  • Fundamental
  • Price
  • RXRX $5.26
  • EVT $24.40
  • Analyst Decision
  • RXRX Buy
  • EVT
  • Analyst Count
  • RXRX 5
  • EVT 0
  • Target Price
  • RXRX $7.00
  • EVT N/A
  • AVG Volume (30 Days)
  • RXRX 32.1M
  • EVT 115.5K
  • Earning Date
  • RXRX 08-07-2025
  • EVT 01-01-0001
  • Dividend Yield
  • RXRX N/A
  • EVT 8.32%
  • EPS Growth
  • RXRX N/A
  • EVT N/A
  • EPS
  • RXRX N/A
  • EVT 6.63
  • Revenue
  • RXRX $59,790,000.00
  • EVT $69,404,302.00
  • Revenue This Year
  • RXRX $23.51
  • EVT N/A
  • Revenue Next Year
  • RXRX $53.87
  • EVT N/A
  • P/E Ratio
  • RXRX N/A
  • EVT $3.55
  • Revenue Growth
  • RXRX 29.32
  • EVT N/A
  • 52 Week Low
  • RXRX $3.79
  • EVT $19.20
  • 52 Week High
  • RXRX $12.36
  • EVT $25.83
  • Technical
  • Relative Strength Index (RSI)
  • RXRX 54.36
  • EVT 71.34
  • Support Level
  • RXRX $4.91
  • EVT $23.89
  • Resistance Level
  • RXRX $5.44
  • EVT $23.75
  • Average True Range (ATR)
  • RXRX 0.36
  • EVT 0.25
  • MACD
  • RXRX 0.01
  • EVT 0.07
  • Stochastic Oscillator
  • RXRX 66.51
  • EVT 94.92

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

About EVT Eaton Vance Tax Advantaged Dividend Income Fund of Beneficial Interest

EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND is a diversified, closed-end management investment company. Its objective is to provide a high level of after-tax total return consisting mainly of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of electric utilities, energy equipment and services, food products, health care providers and services, internet software and services, and other areas.

Share on Social Networks: